Coronavirus: Gilead Readies For Remdesivir Ramp Up, Questions On Profit Motive
Demand Could Be High For Antiviral
If clinical trials prove it effective against COVID-19, remdesivir could potentially help millions of patients - which raises big questions about funding and access.
